OTC Markets OTCPK - Delayed Quote USD

Siemens Healthineers AG (SMMNY)

Compare
26.69
-0.04
(-0.15%)
At close: January 17 at 3:00:00 PM EST
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
22,363,000.00
22,363,000.00
21,680,000.00
21,714,000.00
17,997,000.00
Cost of Revenue
13,895,000.00
13,895,000.00
13,971,000.00
13,577,000.00
11,045,000.00
Gross Profit
8,468,000.00
8,468,000.00
7,709,000.00
8,137,000.00
6,952,000.00
Operating Expense
5,659,000.00
5,659,000.00
5,576,000.00
5,213,000.00
4,384,000.00
Operating Income
2,809,000.00
2,809,000.00
2,133,000.00
2,924,000.00
2,568,000.00
Net Non Operating Interest Income Expense
-283,000.00
-283,000.00
-207,000.00
-127,000.00
-170,000.00
Pretax Income
2,523,000.00
2,523,000.00
1,928,000.00
2,800,000.00
2,404,000.00
Tax Provision
564,000.00
564,000.00
403,000.00
746,000.00
658,000.00
Net Income Common Stockholders
1,942,000.00
1,942,000.00
1,509,000.00
2,038,000.00
1,727,000.00
Diluted NI Available to Com Stockholders
1,942,000.00
1,942,000.00
1,509,000.00
2,038,000.00
1,727,000.00
Basic EPS
0.83
0.87
0.68
0.91
0.79
Diluted EPS
0.83
0.86
0.67
0.91
0.79
Basic Average Shares
2,234,510.50
2,232,183.91
2,235,555.56
2,245,588.00
2,199,380.00
Diluted Average Shares
2,237,348.38
2,245,086.71
2,252,238.81
2,255,492.00
2,207,200.00
Total Expenses
19,554,000.00
19,554,000.00
19,547,000.00
18,790,000.00
15,429,000.00
Net Income from Continuing & Discontinued Operation
1,942,000.00
1,942,000.00
1,509,000.00
2,038,000.00
1,727,000.00
Normalized Income
1,942,000.00
1,942,000.00
1,509,000.00
2,038,000.00
1,727,000.00
Interest Income
119,000.00
119,000.00
85,000.00
48,000.00
33,000.00
Interest Expense
476,000.00
476,000.00
296,000.00
118,000.00
83,000.00
Net Interest Income
-283,000.00
-283,000.00
-207,000.00
-127,000.00
-170,000.00
EBIT
2,999,000.00
2,999,000.00
2,224,000.00
2,918,000.00
2,487,000.00
EBITDA
4,222,000.00
4,222,000.00
3,781,000.00
4,261,000.00
3,526,000.00
Reconciled Cost of Revenue
13,895,000.00
13,895,000.00
13,971,000.00
13,577,000.00
11,045,000.00
Reconciled Depreciation
1,223,000.00
1,223,000.00
1,557,000.00
1,343,000.00
1,039,000.00
Net Income from Continuing Operation Net Minority Interest
1,942,000.00
1,942,000.00
1,509,000.00
2,038,000.00
1,727,000.00
Total Unusual Items Excluding Goodwill
34,000.00
--
--
--
11,000.00
Total Unusual Items
34,000.00
--
--
--
11,000.00
Normalized EBITDA
4,222,000.00
4,222,000.00
3,781,000.00
4,261,000.00
3,526,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
9/30/2021 - 5/14/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

S1YK34.SA Stryker Corporation
117.12
+1.50%
 
KURN.SW Kuros Biosciences AG
22.20
-4.52%
 
NSPR InspireMD, Inc.
2.7243
-2.00%
 
CBLL CeriBell, Inc.
21.04
+4.42%
 
RBOT Vicarious Surgical Inc.
15.85
+11.15%
 
CTSO Cytosorbents Corporation
1.0300
-0.96%
 
SNN Smith & Nephew plc
25.29
+0.96%
 
PHG Koninklijke Philips N.V.
25.80
+0.27%
 
GKOS Glaukos Corporation
156.39
-0.08%
 
BIO Bio-Rad Laboratories, Inc.
342.41
-0.60%